Entity Details

Primary name MYSM1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ5VVJ2
EntryNameMYSM1_HUMAN
FullNameDeubiquitinase MYSM1
TaxID9606
Evidenceevidence at protein level
Length828
SequenceStatuscomplete
DateCreated2006-05-02
DateModified2021-06-02

Ontological Relatives

GenesMYSM1

GO terms

Show/Hide Table
GOName
GO:0002376 immune system process
GO:0003677 DNA binding
GO:0003713 transcription coactivator activity
GO:0004843 thiol-dependent deubiquitinase
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005730 nucleolus
GO:0005737 cytoplasm
GO:0006338 chromatin remodeling
GO:0008237 metallopeptidase activity
GO:0016579 protein deubiquitination
GO:0032991 protein-containing complex
GO:0035522 monoubiquitinated histone H2A deubiquitination
GO:0042393 histone binding
GO:0045944 positive regulation of transcription by RNA polymerase II
GO:0046872 metal ion binding
GO:0070122 isopeptidase activity
GO:1903706 regulation of hemopoiesis

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR000555 JAB1/MPN/MOV34 metalloenzyme domainDomainDomain
IPR001005 SANT/Myb domainDomainDomain
IPR007526 SWIRM domainDomainDomain
IPR009057 Homeobox-like domain superfamilyFamilyHomologous superfamily
IPR017884 SANT domainDomainDomain
IPR033497 Histone H2A deubiquitinase MYSM1FamilyFamily
IPR037518 MPN domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618116 OMIMBone marrow failure syndrome 4 (BMFS4)A form of bone marrow failure syndrome, a heterogeneous group of life-threatening disorders characterized by hematopoietic defects in association with a range of variable extra-hematopoietic manifestations. BMFS4 is characterized by early-onset anemia, leukopenia, decreased B cells, and developmental aberrations including facial dysmorphism, mild skeletal anomalies, and neurodevelopmental delay. BMFS4 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.